Dx Dialogues: Aortic stenosis
- Dx Dialogues
- Dx Dialogues: Aortic stenosis
Dr. Susheel Kodali, MD, professor and director of the Structural Heart and Valve Center at Columbia University Irving Medical Center/NY-Presbyterian Hospital reviews AI's emerging role in aortic stenosis, the ongoing need for long-term TAVR durability data, and how ongoing refinements to valve design may enhance coronary access.
Featured Content
Article
Long-term valve strategy is reshaping TAVR and SAVR decision-making in aortic stenosisDurability, coronary access, and reintervention planning are increasingly influencing treatment selection.
Article
Earlier recognition and emerging AI tools are changing severe aortic stenosis careImaging, referral pathways, and predictive technologies may support earlier intervention strategies.
Article
Aortic stenosis: planning for lifetime valve managementLifetime valve management requires early planning in younger patients.
Article
Early TAVR in asymptomatic aortic stenosis: evolving evidence and practiceTAVR approval for asymptomatic severe AS prompts new questions on timing and selection.
Article
TAVR and SAVR: comparable long-term outcomes in low-risk patientsTrial data show comparable long-term outcomes, with differences in thrombosis and pacemaker rates.
Article
TAVR indications expand across risk and age groupsTAVR indications now include asymptomatic patients, with increasing use in younger populations.
